The lancet. Diabetes & endocrinology
Empagliflozin in chronic kidney disease: evidence for early, inclusive, and confident use.
Carmine Zoccali, Francesca Mallamaci
Published: 202510.1016/S2213-8587(25)00224-4
No abstract available for this study.
Carmine Zoccali, Francesca Mallamaci
No abstract available for this study.